Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
10,548,060
-
Share change
-
+2,020,139
-
Total reported value
-
$51,052,315
-
Price per share
-
$4.84
-
Number of holders
-
34
-
Value change
-
+$10,425,733
-
Number of buys
-
18
-
Number of sells
-
11
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q4 2025
As of 31 Dec 2025,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,548,060 shares.
The largest 10 holders included
B Group, Inc., UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, Long Focus Capital Management, LLC, BlackRock, Inc., NOMURA ASSET MANAGEMENT INTERNATIONAL INC., MARSHALL WACE, LLP, CITADEL ADVISORS LLC, MORGAN STANLEY, LPL Financial LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
34
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.